Previous studies have reported that in patients with MPM, PD-L1 overexpression in the tumor microenvironment (TME) is a poor prognostic factor13–15, but other studies, including our previous study, revealed that PD-L1 status has no influence on the prognosis of patients with MPM16–18. Here, CD274 is linked to neoplasm.